#news #biotech Abpro files $69M IPO to take bispecific antibodies into the clinic

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Abpro files $69M IPO to take bispecific antibodies into the clinic .Preclinical-stage biotech Abpro Therapeutics has filed a $69 million IPO that it hopes will fund clinical trials of its lead antibody drugs for cancer and vascular eye disease due to start next year.

from FierceBiotech: Biotech https://ift.tt/2GVLfbZ